| 1 |
Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection [J]. Nat Rev Cancer, 2005,5(11):845-856.
|
| 2 |
Bellon E, Ligtenberg MJ, Tejpar S, et al. External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment rounds [J]. Oncologist, 2011,16(4):467-478.
|
| 3 |
Deans ZC, Bilbe N, O′Sullivan B, et al. Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment [J]. J Clin Pathol, 2013, 66(4):319-325.
|
| 4 |
Emile JF, Tisserand J, Bergougnoux L, et al. Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group [J]. BMC Cancer, 2013, 13:472.
|
| 5 |
Normanno N, Fenizia F, Castiglione F, et al. External quality assessment for EGFR mutations in Italy: improvements in performances over the time [J]. ESMO Open, 2017,2(2):e000160.
|
| 6 |
Normanno N, Pinto C, Castiglione F, et al. The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences [J]. J Transl Med, 2015, 13:287.
|
| 7 |
Boleij A, Tops BB, Rombout PD, et al. RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers [J]. Oncotarget, 2015,6(17):15681-15689.
|
| 8 |
Zhang R, Ding J, Han Y, et al. The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China [J]. Oncotarget, 2016,7(36):58500-58515.
|
| 9 |
Zhang R, Peng R, Li Z, et al. Synthetic Circulating Cell-free DNA as Quality Control Materials for Somatic Mutation Detection in Liquid Biopsy for Cancer [J]. Clin Chem, 2017,63(9):1465-1475.
|
| 10 |
Xiao Y, Gao X, Maragh S, et al. Cell lines as candidate reference materials for quality control of ERBB2 amplification and expression assays in breast cancer [J]. Clin Chem, 2009,55(7):1307-1315.
|
| 11 |
Dijkstra JR, Opdam FJ, Boonyaratanakornkit J, et al. Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysis [J]. J Mol Diagn, 2012,14(3):187-191.
|
| 12 |
Zhang R, Han Y, Huang J, et al. Results of first proficiency test for KRAS testing with formalin-fixed, paraffin-embedded cell lines in China [J]. Clin Chem Lab Med, 2014,52(12):1851-1857.
|
| 13 |
Patton S, Normanno N, Blackhall F, et al. Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing [J]. Br J Cancer, 2014,111(2):413-420.
|
| 14 |
Dumur CI, Almenara JA, Powers CN, et al. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing [J]. Diagn Pathol, 2015,10:169.
|
| 15 |
Li Y, Zhang R, Han Y, et al. Comparison of the types of candidate reference samples for quality control of human epidermal growth factor receptor 2 status detection [J]. Diagn Pathol, 2016,11(1):85.
|
| 16 |
Li Y, Zhang R, Peng R, et al. Reliability Assurance of Detection of EML4-ALK Rearrangement in Non-Small Cell Lung Cancer: The Results of Proficiency Testing in China [J]. J Thorac Oncol, 2016, 11(6):924-929.
|
| 17 |
Jia S, Zhang R, Lin G, et al. A novel cell line generated using the CRISPR/Cas9 technology as universal quality control material for KRAS G12V mutation testing [J]. J Clin Lab Anal, 2018 [Epub ahead of print]
|
| 18 |
Peng R, Zhang R, Lin G, et al. CRISPR/Cas9 Technology-Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing [J]. J Mol Diagn, 2017,19(5): 766-775.
|
| 19 |
Zook JM, Catoe D, McDaniel J, et al. Extensive sequencing of seven human genomes to characterize benchmark reference materials [J]. Sci Data, 2016,3:160025.
|
| 20 |
Cornish A, Guda C. A Comparison of Variant Calling Pipelines Using Genome in a Bottle as a Reference [J]. Biomed Res Int, 2015, 2015:456479.
|